Searchable abstracts of presentations at key conferences in endocrinology

ea0099ep257 | Endocrine-Related Cancer | ECE2024

The value of cumulative serum 5-HIAA exposure in diagnostics of carcinoid heart disease: A prospective follow up in patients with small intestinal neuroendocrine tumors

Kostiainen Iiro , Simonen Piia , Aaltonen Katri , Linden Riikka , Karppinen Noora , Gordin Daniel , Rapola Janne , Schalin-Jantti Camilla , Matikainen Niina

Introduction: In small intestinal neuroendocrine tumors (SI-NET), unphysiological exposure to serotonin is considered as a major pathogenic factor predisposing to the development carcinoid heart disease (CHD), a complication of carcinoid syndrome associated with poor prognosis. The ability of biomarkers to predict the development of CHD is limited. The aim of our prospective study was to assess risk factors of CHD development and mortality in SI-NET.Meth...

ea0073pep9.5 | Presented ePosters 9: Endocrine-Related Cancer | ECE2021

Endothelial and vascular function, biomarkers and clinical presentation in patients with small intestine NETs

Kostiainen Iiro , Rosengård-Bärlund Milla , Karppinen Noora , Simonen Piia , Rapola Janne , Lindén Riikka , Schalin-Jäntti Camilla , Matikainen Niina

Background20–30% of patients with metastatic small intestine neuroendocrine tumours (SI-NETs) suffer from carcinoid syndrome (CS), i.e. diarrhea, flushing, and bronchospasm. Of these, 25–50% develop carcinoid heart disease (CHD) characterized by valve fibrosis and right heart failure. There are no early predictive markers of CHD, which typically is diagnosed in the advanced stage.Aims of the studyTo...